Assumptions by scenario

30
The control and elimination (I, II) scenarios have different assumptions in terms of project 31 implementation: the expected start years of potential new projects and the treatment duration. The 32 details are described in Kim et al. 2015 (2) . 
Prediction of the trends in infection and symptoms by endemicity stratum
41
We predicted the trends in the prevalence of infection and symptoms (severe itching, low vision, 42 blindness) by age group and sex for the subdivided areas (hyper-, meso-, hypo-, non-endemic) 43 within a project over 2013-2045, taking into account the overall endemcity level of the project and 44 the prevailing type of infection: 1) the savanna type with high prevalence of vision impairment and 45
2) the forest/mixed type with low prevalence of vision impairment. Similar to Coffeng et al. (3) , 46 simulations were done only for hyper-and meso-endemicity settings; we assumed the prevalence 47 of infection and symptoms in hypo-endemic setting to be one-third of that in meso-endemic setting. 48
Considering the stochastic nature of the model, trends were estimated as the average trend from 49 150 repeated simulation runs. 50
Example: a project Adamaoua 1 in Cameroon 51
 Predicted trends of infection and symptoms by sex and age group for hyper-, meso-, and hypo-52 endemicity areas within the project under the elimination scenario II. 53 
Prediction of the number of cases by age group and sex
60
To predict the number of cases of infection and symptoms by age group and sex over 61 we multiplied the respective predicted prevalence of cases by population. The 2011 population at 62 project level was decomposed to age group and sex using the country-specific distribution of 63 population by age group and sex (4), and projected for the entire time horizon using the population 64 growth rates (4) . Then, to calculate the distribution of population by endemicity within a project 65 area, we used the proportion of surface for each endemicity level as a proxy for the distribution of 66 population, assuming population is evenly distributed. 
DALYs estimation
Health Impacts
100
Parameters against which we assessed the robustness of health impacts (the number of cases of 101 severe itching, low vision, and blindness and DALYs) were the treatment coverage, the level of 102 infection and morbidity in hypo-endemic areas relative to meso-endemic areas, the reduction of 103 life-expectancy due to blindness, and the population growth rate. 104
a. Treatment coverage 105
As an expected treatment coverage rate for the period 2013-2045, we used the average 106 treatment coverage over the period 2010-2012 for APOC countries and the most recent 107 available data (as of November 2013) for former OCP countries due to the lack of history 108 data. To incorporate the uncertainty about treatment coverage rates, we assigned a beta 109 distribution and fitted to the pool of treatment coverage data for projects at country level. 110
The beta distribution at regional level was fitted to the pool of national average treatment 111 coverage (S1 Table) . The range of treatment coverage was restricted to 60% to 84%, because 112 at least 60% is required for effective control of the disease and 84% is the maximum 113 achievable considering 16% of the population is not eligible for CDTi due to ages less than 114 five years, pregnancy, or severe illness (2) . 115 S1 
A database for the former OCP countries had only the most recent available treatment coverage as of November 2013. 4 The standard deviation was assumed to be 10% of the treatment coverage. We did not conduct ONCHOSIM simulations for hypo-endemic areas, as ONCHOSIM 128 predicts that the infection level in hypo-endemic areas is unsustainable without human or 129 vector migration, and data on human or vector migration were unavailable. Instead, we 130 assumed that the level of infection and morbidity in hypo-endemic areas is 1/3 relative to that 131 in meso-endemic areas. To incorporate the uncertainty about this assumption, we applied a 132 triangular distribution with the lower limit to be 1/10, the upper limit to be 1/2, and the mode 133 to be 1/3. 134 c. Life-expectancy loss per blindness incidence 136
We assumed that blindness causes 8 years of life-expectancy loss (3). To incorporate the 137 uncertainty about this assumption, we applied a triangular distribution with the lower limit to 138 be 4, the upper limit to be 12, and the mode to be 8. 139 140
d. Population growth rate 141
We assigned a normal distribution to each country by fitting to low, medium, and high 142 population growth rates. The distribution has the medium as the average and half of the 143 distance between the low and high rates as the standard deviation. Data were available from 144 the UN database (4). 145 146
Health workforce needs
147
Parameters against which we examined the robustness of the health workforce needs were the ratio 148 of community volunteers over population, the ratio of community health workers over population, 149 the possible delay in starting and ending CDTi, and the population growth rate. 150 151
a. The ratio of community volunteers over population 152
We applied a beta distribution and fitted to available data at country and regional levels. The 153 ratio of community volunteers over population was available for 67 of total 112 ongoing 154 projects (as of November 2013) in sub-Saharan Africa from project budget documents 155 (Y2012). For projects in countries for which data were available, we used the fitted 156 distribution at country level; for projects in countries with no data, we used the distribution at 157 regional level which was fitted to available national average ratios among endemic African 158 countries. The fitted distributions are presented in S2 
b. The ratio of community health workers over population 163
We used the same method for the ratio of community volunteers over population described 164 above. The ratio of community health workers over population was available for 67 of total 165 112 ongoing projects (as of November 2013) in sub-Saharan Africa from project budget 166 documents (Y2012). The fitted distributions are presented in S3 
c. Delay in starting CDTi 171
We assumed that starting CDTi can be delayed as long as 5 years. We applied a gamma 172 distribution in which 90% of samples fall into the range of 0 and 5 ( S7 Fig) . We assumed that ending CDTi can be also delayed as long as 5 years. We applied a gamma 177 distribution in which 90% of samples fall into the range of 0 and 5 (S7 Figure) . We assumed that country-specific outpatient service costs per visit, available from WHO-189 CHOICE database (6), would be stable over the entire time horizon (S4 Table) . To 190 incorporate the uncertainty about this parameter, we applied a gamma distribution for each 191 country assuming the standard deviation to be 20% of the outpatient costs per visit. The proxy for health facility utilization rate was the average therapeutic coverage for the first 195 year of CDTi based on community-based surveys in multiple endemic African countries (7) . 196 We assigned a normal distribution using the mean, 40%, and SD, 15%, from the surveys at 197 project level. 198
c. The number of patients with severe itching and low vision 199
The number of patients with severe itching and low vision is one of the health impacts results. 200
The methods to incorporate the uncertainty about this parameter are described in Section 1. 201 202 S4 (6); Adjusted for country-specific inflation over 2009-2013 (8) and converted to 2013 USD using market exchange rate (9); Outpatient visit costs exclude drug and laboratory diagnosis. b Data from WHO (10). This excludes transportation costs. c Outpatient service cost per visit was estimated before Sudan was divided, so we used the same as that for Sudan. Out-of-pocket payments as proportion of total health expenditure were available for each 212 country from WHO database (10) (S4 Table) . To incorporate the uncertainty about this 213 parameter, we applied a gamma distribution for each country assuming the standard deviation 214 to be 20% of the data. 215 216
b. Transportation costs 217
Our assumption on transportation costs, 17% of outpatient visit costs, was based on the multi-218 country survey for 39 countries, available from 2010 World Health Report (11) . This survey 219
shows that the average transportation cost as percentage of outpatient visit costs across 14 220 sub-Saharan African countries is 17% and the standard deviation is 11%. To incorporate the 221 uncertainty about this parameter, we applied a gamma distribution assuming the mean is 17% 222 and the standard deviation to be 11%. 223 224
Economic impacts
225
To examine the robustness of the economic productivity in the PSA, we included GDP per capita, 226 the employment rate, the proportion of GDP per capita associated with productivity losses due to 227 severe itching, low vision, and blindness. 228 229 a. GDP per capita (a proxy for income during healthy years) 230
To incorporate the uncertainty about GDP per capita as an income during healthy years, we 231 applied a triangular distribution using GDP per capita as the mode, the average minimum 232 wage among endemic countries as the lower limit, 62% of GDP per capita (S6 Table) (12) . b Adjusted for labor force participation rate, i.e., (1-unemployment rate)*( % of population ages 15 and older that is economically active); Unemployment rate from World Bank (13); Labor force participation rate from World Bank (14) c Data were missing. We used data for sub-Saharan Africa from World Bank (13, 14) .
243
c. Productivity loss due to skin itching 244
We based our assumption about the productivity loss due to skin itching on two surveys in 245 Ethiopia. One survey shows that intermediate onchocercal skin diseases (OSD) cause the 246 income loss by 10% and severe OSD, by 16% (15); and another survey shows the income loss 247 by 25% (16) . The productivity loss due to skin itching was assumed to be 19% of GDP per 248 capita, the average of the two studies' results, 13% (average of 10% and 16%) and 25%. To 249 incorporate the uncertainty about this parameter, we applied a triangular distribution in which 250 the mode is 19%, the lower limit, 10%, and the upper limit, 25%. 251 252
d. Productivity loss due to low vision 253
We based our assumption about the productivity loss due to low vision, 38% of GDP per 254 capita, on the survey in Guinea (17) . We applied a normal distribution in which the mean is 255 38% and the standard deviation is 20% of the mean. 256 257 e. Productivity loss due to blindness 258
We based our assumption about the productivity loss due to blindness, 79% of GDP per 259 capita, on the survey in Guinea (17) . We applied a normal distribution in which the mean is 260 79% and the standard deviation is 20% of the mean. 261 262
Simulations
263
For the PSA for each result, we ran simulation 500 times by sampling from the described 264 distributions. 265
